High‐grade brain tumors in siblings with biallelic MSH6 mutations
暂无分享,去创建一个
[1] U. Lehmann,et al. Constitutional mismatch repair deficiency and childhood leukemia/lymphoma – report on a novel biallelic MSH6 mutation , 2010, Haematologica.
[2] K. Wimmer,et al. Constitutional mismatch repair-deficiency syndrome , 2010, Haematologica.
[3] Stephen Yip,et al. MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance , 2009, Clinical Cancer Research.
[4] P. Levonian,et al. Compound heterozygosity for MSH6 mutations in a pediatric lymphoma patient. , 2009, Journal of pediatric hematology/oncology.
[5] K. Wimmer,et al. Constitutional mismatch repair-deficiency syndrome: have we so far seen only the tip of an iceberg? , 2008, Human Genetics.
[6] J. Hainfellner,et al. RNA‐based mutation analysis identifies an unusual MSH6 splicing defect and circumvents PMS2 pseudogene interference , 2008, Human mutation.
[7] J. Saurin,et al. Novel biallelic mutations in MSH6 and PMS2 genes: gene conversion as a likely cause of PMS2 gene inactivation , 2007, Human mutation.
[8] N. Rahman,et al. Medulloblastoma, acute myelocytic leukemia and colonic carcinomas in a child with biallelic MSH6 mutations , 2007, Nature Clinical Practice Oncology.
[9] J. Østergaard,et al. Neurofibromatosis von Recklinghausen type I phenotype and early onset of cancers in siblings compound heterozygous for mutations in MSH6 , 2005, American journal of medical genetics. Part A.
[10] P. Peltomäki,et al. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome? , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] C. Richards,et al. A Homozygous Mutation in MSH6 Causes Turcot Syndrome , 2005, Clinical Cancer Research.
[12] G. Meijer,et al. A Homozygous MSH6 Mutation in a Child with Café-au-Lait Spots, Oligodendroglioma and Rectal Cancer , 2004, Familial Cancer.
[13] T. Ozcelik,et al. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. , 1999, Cancer research.